![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.1, Iss.7, 2000-12, pp. : 1331-1342
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The Role of Protease Inhibitor Therapy in Children with HIV Infection
Pediatric Drugs, Vol. 4, Iss. 9, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Metabolic Complications Associated with HIV Protease Inhibitor Therapy
By Nolan D.
Drugs, Vol. 63, Iss. 23, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Atazanavir: a novel HIV-1 protease inhibitor
Expert Opinion on Investigational Drugs, Vol. 11, Iss. 9, 2002-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Review of HIV-1 Protease Inhibitor Assay Methods
Current Pharmaceutical Analysis, Vol. 3, Iss. 3, 2007-08 ,pp. :